Purchase Order HHSN275201700612P
Award Date 8/9/17
Potential Completion Date 2/8/18
Potential Value $94K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. for $126,850.00. The contract is for research services related to the "Blood Stability and Metabolism of MTS-IV-39 Analogs." This work supports NIDDK's research program and was not set aside for any specific business category. Frontage Laboratories is a full-service contract...
- This is a $116,500.00 firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. The contract is for the provision of various research services, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments, to support the development of new therapies and investigational drugs. There is no set-aside...
- This is a $117,000.00 firm fixed price purchase order awarded to Frontage Laboratories, Inc. by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The contract is for Frontage Laboratories to provide a range of preclinical research services, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments, to support the development of new therapies and...
- This is a $19,000 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO). The contract is for the synthesis of SAMT-247 and an analog compound. Frontage Laboratories has previously supported NIDDK and the National Center for Advancing Translational Sciences through various federal contracts, providing services such as pharmacokinetic testing, in...
- This is a $34,000.00 firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO), for an intravaginal female fertility study. The contract will run through January 5, 2024. Frontage Laboratories has previously conducted a range of preclinical research services for NIDDK and the National Center for Advancing Translational Sciences, including...
- This firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Valued at $155,100, the contract calls for Frontage Laboratories Inc. to provide services in support of compound 21 testing and in vivo pharmacokinetics studies. Specifically, the prime contractor will scale up production of compound 21 to deliver 10...
- The National Institutes of Health awarded a $36.2K purchase order to Frontage Laboratories, Inc., a minority-owned, Asian-Pacific American owned business, for method development validation work under POTS# 09-030459. The contract, issued on May 22, 2009, with an ultimate completion date of May 21, 2010, was executed at firm fixed price with no set-aside designation, indicating the contractor competed successfully in an open bidding process. Work was performed at Frontage Laboratories' facility...
- This federal contract award is for the synthesis of Fmoc-thyclotide monomers, placed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) with the prime contractor Frontage Laboratories, Inc. The $45,500.00 firm-fixed-price purchase order has an ultimate completion date of December 31, 2020. Frontage Laboratories, a minority-owned, Asian-Pacific American-owned business, has an established history of providing specialized research services to NIDDK and other NIH...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $88,000 firm fixed price purchase order to Frontage Laboratories, Inc., a full-service contract research organization, to provide specialized pharmacokinetic and metabolism research services. The contract supports NIDDK's efforts to advance the testing of a new class of antiviral molecules by conducting blood stability studies, rat and mouse pharmacokinetic studies, and in vitro hepatocyte metabolism studies...
- The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $90,000.00 firm fixed price purchase order contract to Frontage Laboratories, Inc. for the synthesis of thyclotides (R,R). The contract has no set-aside designation and was awarded on August 14, 2022 with an ultimate completion date of August 17, 2023. Frontage Laboratories, a minority-owned, Asian-Pacific American manufacturer of goods, has provided a range of research...